IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-981-99-2909-2_17.html
   My bibliography  Save this book chapter

A Conceptual Framework for Impact of Artificial Intelligence and Machine Learning (AIML) in Drug Development Within Pharmaceutical Industry

In: Innovation-Driven Business and Sustainability in the Tropics

Author

Listed:
  • Mugdha Hemant Belsare

    (Swiss School of Business and Management)

  • Josip Burusic

    (University of Zagreb)

Abstract

A conceptual framework is proposed within the scope of this study, which focuses on determining impact of AI in drug discoveries in pharmaceutical industry in India region. This is achieved by identifying internal and external determinants which are most significant to the success of the AI in Pharma. In the pharmaceutical sector, lowering prices and speeding up the development of new drugs has become a demanding and pressing issue. The pharmaceutical industry is expanding at a lightning speed in the pandemic time frame. The global pharmaceutical business is on the verge of a new paradigm, as rapid advances in artificial intelligence bring up the possibility of producing more effective drugs faster and at a lower cost. Artificial intelligence has the potential to revolutionize pharmaceutical industry as AI and new deep learning techniques have opened the pathway for modern drug development. Machine learning is a branch of AI that comprises the compilation of mathematical formulae and advanced statistics that researchers use through algorithms to solve real-world issues. AI has the potential to increase drug approval rates, lower development costs, accelerate the delivery of pharmaceuticals to patients and assist patients in complying to their treatment regimens. AI technology has a promising future in drug development, but the disparity across the domains is a significant blocking point, which this framework shall help to understand based on the internal and external determinants. This model is based on systematic literature review of most relevant ABDC journal publications. Developed conceptual framework will be helpful to the CEO, CXOs, business leaders and managers of the Pharma companies, while making strategic decision and action plan for execution. This shall help to gain the knowledge proactively acquired and deeply tested to implement and enjoy the results in making strong decisions. Using the most cutting-edge AI-based technologies not only shortens the time it takes for items to reach the market, but also raises product quality, ensures worker safety, maximises resource utilisation, and reduces production costs, which are the focus areas from the conceptual framework. Future research on confirming the conceptual framework, identifying most and least impactful factors, will involve formal collection and analysis of empirical data.

Suggested Citation

  • Mugdha Hemant Belsare & Josip Burusic, 2023. "A Conceptual Framework for Impact of Artificial Intelligence and Machine Learning (AIML) in Drug Development Within Pharmaceutical Industry," Springer Books, in: Emiel L. Eijdenberg & Malobi Mukherjee & Jacob Wood (ed.), Innovation-Driven Business and Sustainability in the Tropics, chapter 0, pages 291-307, Springer.
  • Handle: RePEc:spr:sprchp:978-981-99-2909-2_17
    DOI: 10.1007/978-981-99-2909-2_17
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-981-99-2909-2_17. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.